The question asks for the minimum manufacturing space required for Habb, a Unani dosage form, under Schedule T of the Drugs and Cosmetics Act. Let's weigh the four area options against how Schedule T scales space requirements to the dosage form.
Since Habb is prepared by a simple compounding process, it falls into the lower area bracket of Schedule T rather than the larger one reserved for more equipment-heavy forms.
Therefore, the correct answer is 100 Sq. Ft..

List I | List II | ||
|---|---|---|---|
| A | \(\Omega^{-1}\) | I | Specific conductance |
| B | \(∧\) | II | Electrical conductance |
| C | k | III | Specific resistance |
| D | \(\rho\) | IV | Equivalent conductance |
List I | List II | ||
|---|---|---|---|
| A | Constant heat (q = 0) | I | Isothermal |
| B | Reversible process at constant temperature (dT = 0) | II | Isometric |
| C | Constant volume (dV = 0) | III | Adiabatic |
| D | Constant pressure (dP = 0) | IV | Isobar |